BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7948148)

  • 1. Effect of exogenous nerve growth factor on neurotoxicity of and neuronal gene delivery by a herpes simplex amplicon vector in the rat brain.
    Pakzaban P; Geller AI; Isacson O
    Hum Gene Ther; 1994 Aug; 5(8):987-95. PubMed ID: 7948148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene transfer to the nigrostriatal system by hybrid herpes simplex virus/adeno-associated virus amplicon vectors.
    Costantini LC; Jacoby DR; Wang S; Fraefel C; Breakefield XO; Isacson O
    Hum Gene Ther; 1999 Oct; 10(15):2481-94. PubMed ID: 10543613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Introduction of a foreign gene (Escherichia coli lacZ) into rat neostriatal neurons using herpes simplex virus mutants: a light and electron microscopic study.
    Huang Q; Vonsattel JP; Schaffer PA; Martuza RL; Breakefield XO; DiFiglia M
    Exp Neurol; 1992 Mar; 115(3):303-16. PubMed ID: 1311266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nerve growth factor protects against herpes simplex virus type 1 neurotoxicity in the rat striatum.
    Pakzaban P; Chiocca EA
    Neuroreport; 1994 Apr; 5(8):993-6. PubMed ID: 8061311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved herpes simplex virus type 1 amplicon vectors for proportional coexpression of positron emission tomography marker and therapeutic genes.
    Jacobs AH; Winkeler A; Hartung M; Slack M; Dittmar C; Kummer C; Knoess C; Galldiks N; Vollmar S; Wienhard K; Heiss WD
    Hum Gene Ther; 2003 Feb; 14(3):277-97. PubMed ID: 12639307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Herpes vector-mediated delivery of marker genes to disseminated central nervous system tumors.
    Kramm CM; Rainov NG; Sena-Esteves M; Chase M; Pechan PA; Chiocca EA; Breakefield XO
    Hum Gene Ther; 1996 Feb; 7(3):291-300. PubMed ID: 8835217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A system, using neural cell lines, to characterize HSV-1 vectors containing genes which affect neuronal physiology, or neuronal promoters.
    Geller AI
    J Neurosci Methods; 1991 Jan; 36(1):91-103. PubMed ID: 1648153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene therapy using replication-defective herpes simplex virus vectors expressing nerve growth factor in a rat model of diabetic cystopathy.
    Sasaki K; Chancellor MB; Goins WF; Phelan MW; Glorioso JC; de Groat WC; Yoshimura N
    Diabetes; 2004 Oct; 53(10):2723-30. PubMed ID: 15448108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of the helper virus on expression of beta-galactosidase from a defective HSV-1 vector, pHSVlac.
    Geller AI
    J Virol Methods; 1991; 31(2-3):229-38. PubMed ID: 1650784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.
    Jacobs A; Tjuvajev JG; Dubrovin M; Akhurst T; Balatoni J; Beattie B; Joshi R; Finn R; Larson SM; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO; Blasberg RG
    Cancer Res; 2001 Apr; 61(7):2983-95. PubMed ID: 11306477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of ex vivo transduction of mesencephalic reaggregates with bcl-2 on grafted dopamine neuron survival.
    Sortwell CE; Bowers WJ; Counts SE; Pitzer MR; Fleming MF; McGuire SO; Maguire-Zeiss KA; Federoff HJ; Collier TJ
    Brain Res; 2007 Feb; 1134(1):33-44. PubMed ID: 17196186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged in vivo gene expression driven by a tyrosine hydroxylase promoter in a defective herpes simplex virus amplicon vector.
    Jin BK; Belloni M; Conti B; Federoff HJ; Starr R; Son JH; Baker H; Joh TH
    Hum Gene Ther; 1996 Oct; 7(16):2015-24. PubMed ID: 8930662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An efficient deletion mutant packaging system for defective herpes simplex virus vectors: potential applications to human gene therapy and neuronal physiology.
    Geller AI; Keyomarsi K; Bryan J; Pardee AB
    Proc Natl Acad Sci U S A; 1990 Nov; 87(22):8950-4. PubMed ID: 2174168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Latency associated promoter transgene expression in the central nervous system after stereotaxic delivery of replication-defective HSV-1-based vectors.
    Scarpini CG; May J; Lachmann RH; Preston CM; Dunnett SB; Torres EM; Efstathiou S
    Gene Ther; 2001 Jul; 8(14):1057-71. PubMed ID: 11526453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Herpes simplex virus type 1 amplicon vectors with glucocorticoid-inducible gene expression.
    Lu B; Federoff HJ
    Hum Gene Ther; 1995 Apr; 6(4):419-28. PubMed ID: 7612699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bcl-2 and GDNF delivered by HSV-mediated gene transfer act additively to protect dopaminergic neurons from 6-OHDA-induced degeneration.
    Natsume A; Mata M; Goss J; Huang S; Wolfe D; Oligino T; Glorioso J; Fink DJ
    Exp Neurol; 2001 Jun; 169(2):231-8. PubMed ID: 11358438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delivery of herpes simplex virus amplicon-based vectors to the dentate gyrus does not alter hippocampal synaptic transmission in vivo.
    Dumas T; McLaughlin J; Ho D; Meier T; Sapolsky R
    Gene Ther; 1999 Oct; 6(10):1679-84. PubMed ID: 10516716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene transfer into experimental brain tumors mediated by adenovirus, herpes simplex virus, and retrovirus vectors.
    Boviatsis EJ; Chase M; Wei MX; Tamiya T; Hurford RK; Kowall NW; Tepper RI; Breakefield XO; Chiocca EA
    Hum Gene Ther; 1994 Feb; 5(2):183-91. PubMed ID: 8186298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Herpes simplex virus vector-mediated delivery of glial cell line-derived neurotrophic factor rescues erectile dysfunction following cavernous nerve injury.
    Kato R; Wolfe D; Coyle CH; Huang S; Wechuck JB; Goins WF; Krisky DM; Tsukamoto T; Nelson JB; Glorioso JC; Chancellor MB; Yoshimura N
    Gene Ther; 2007 Sep; 14(18):1344-52. PubMed ID: 17611585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor activity and reporter gene transfer into rat brain neoplasms inoculated with herpes simplex virus vectors defective in thymidine kinase or ribonucleotide reductase.
    Boviatsis EJ; Scharf JM; Chase M; Harrington K; Kowall NW; Breakefield XO; Chiocca EA
    Gene Ther; 1994 Sep; 1(5):323-31. PubMed ID: 7584098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.